Israeli startup Intensix is trialing an Intensive Care Unit patient monitoring system, which gives an early warning of impending sepsis and organ failure that kills 30% of ICU patients, and scientists at Israel’s Technion have discovered how to use proteins to suppress unwanted gene activity.
By: Michael Ordman
ISRAEL’S MEDICAL ACHIEVEMENTS
Detecting the dangers in ICU
Israeli startup Intensix is trialing an Intensive Care Unit patient monitoring system at Tel Aviv Sourasky (Ichalov) hospital. Using data collected from 8,000 patients over the past 8 years, the system gives an early warning of impending sepsis and organ failure that kills 30% of ICU patients.
Control disease – deactivate genes
Scientists at Israel’s Technion have discovered how to use proteins to suppress unwanted gene activity. It could lead to a cure for cystic fibrosis and sickle-cell anemia, as well as more common diseases that are caused by gene activity or mutations, such as many forms of cancer.
Protecting USA from radiation sickness
I previously reported (here) on the therapy from Israel’s Pluristem for treating patients exposed to lethal radiation doses. Pluristem is to join the US National Institute of Allergy and Infectious Diseases program designed to protect people from catastrophic incidents.
Keeping hip and spinal surgeons on target
Another great invention from the students of the Hebrew University of Jerusalem’s BioDesign Medical Innovation program. Their BendGuide system monitors and detects minute changes in guide-wire trajectory during hip and spinal surgery. Surgeons can correct drilling trajectories, prevent guide-wire breakage and significantly reduce operation time while increasing safety.
Another test for Alzheimer’s
Researchers from Tel Aviv University, the Technion and Rambam Medical Center propose testing the blood biomarker ADNP for cognitive aging and Alzheimer’s disease. ADNP is essential for brain formation and cognitive function. I reported another blood test in January (here).
Alzheimer’s therapy is available
I reported previously on the neuroAD transcranial magnetic stimulation (TMS) and cognitive training from Israel’s Neuronix (see here). NeuroAD now has CE approval and is commercially available in Israel, Europe and Asia. US FDA approval is subject to results of latest trials.
Exercise and dance to reduce Parkinson’s symptoms
I reported previously (in August) that dancing can treat Parkinson’s. Now Israeli Alex Kerten has developed a mind-body therapy for Parkinson’s called Gyro-Kinetics. It includes breathing exercises, relaxation and dance.
An app to check your eyesight
Israeli startup 6over6’s GlassesOn smartphone app helps check your latest lens prescription without having to visit an optometrist. It can also help those buying spectacles on-line and in developing countries. The app won the startup contest at the mHealth Israel Conference in Tel Aviv.
Click here for all of this week’s Good News from Israel.